recombinant fowlpox-cea(6d)/tricom vaccine
Vaccineexperimental
Clinical trial activity
8 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
6
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2000 (NCT00009958)
Timeline
Indications
Studied for
- Adenocarcinoma · Phase 1
- Breast Neoplasms · Phase 2
- Breast Neoplasms, Male · Phase 1
- Carcinoma, Hepatocellular · Phase 1
- Carcinoma, Non-Small-Cell Lung · Phase 1
- Colonic Neoplasms · Phase 1
- Colorectal Neoplasms · Phase 1
- Gallbladder Neoplasms · Phase 1
- Intestinal Neoplasms · Phase 1
- Liver Neoplasms · Phase 1
- Lung Neoplasms · Phase 1
- Neoplasm Metastasis · Phase 1/Phase 2
- Neoplasms · Phase 1
- Ovarian Neoplasms · Phase 1
- Pancreatic Neoplasms · Phase 1
- Salivary Gland Neoplasms · Phase 1
- Small Cell Lung Carcinoma · Phase 1
- Stomach Neoplasms · Phase 1
- Testicular Neoplasms · Phase 1
- Thyroid Neoplasms · Phase 1
Mechanism of action
- Carcinoembryonic antigen-related cell adhesion molecule 5Immunity, active
CEACAM5 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- recombinant fowlpox-cea(6d)/tricom vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00128622 | Phase 1 | Sep 1, 2005 | Duke University, National Cancer Institute (NCI) |
| NCT00217373 | Phase 1 | Jun 1, 2005 | National Cancer Institute (NCI), Ohio State University |
| NCT00091039 | N/A | Aug 1, 2004 | National Cancer Institute (NCI) |
| NCT00088933 | Phase 1 | Jun 1, 2004 | Georgetown University, National Cancer Institute (NCI) |
| NCT00048893 | Phase 1/Phase 2 (Phase 2) | Nov 1, 2002 | National Cancer Institute (NCI), National Institutes of Health (NIH) |
| NCT00052351 | Phase 2 | Sep 1, 2002 | National Cancer Institute (NCI) |
| NCT00028496 | Phase 1 | Nov 1, 2001 | National Cancer Institute (NCI), Temple University |
| NCT00009958 | Phase 1 | Nov 1, 2000 | Georgetown University, National Cancer Institute (NCI) |
Showing 8 of 8 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Cancer Institute (NCI) | Government | 8 | 7 | 3 | 2000 |
| Georgetown University | Academic/Hospital | 2 | 0 | 1 | 2000 |
| Duke University | Academic/Hospital | 1 | 1 | 1 | 2005 |
| National Institutes of Health (NIH) | Government | 1 | 0 | 1 | 2002 |
| Ohio State University | Academic/Hospital | 1 | 0 | 1 | 2005 |
| Temple University | Academic/Hospital | 1 | 0 | 1 | 2001 |
6 organizations
Page 1 / 1